Lincoln Capital LLC Pfizer Inc Transaction History

Lincoln Capital LLC

$461 Million
Q3 2024

A detailed history of Lincoln Capital LLC transactions in Pfizer Inc stock. As of the latest transaction made, Lincoln Capital LLC holds 13,591 shares of PFE stock, worth $359,210. This represents 0.09% of its overall portfolio holdings.

Number of Shares

13,591

Previous 13,659 0.5%

Holding current value

$359,210

Previous $382,000 2.88%

% of portfolio

0.09%

Previous 0.09%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$27.7 - $31.39 $1,883 - $2,134	-68 Reduced 0.5%	13,591 $393,000
Q2 2024 Jul 22, 2024	BUY	$25.26 - $29.6 $27,786 - $32,560	1,100 Added 8.76%	13,659 $382,000
Q3 2023 Oct 10, 2023	BUY	$32.09 - $37.51 $18,291 - $21,380	570 Added 4.75%	12,559 $416,000
Q1 2023 Apr 26, 2023	SELL	$39.39 - $51.28 $11,501 - $14,973	-292 Reduced 2.38%	11,989 $489,000
Q4 2022 Jan 18, 2023	SELL	$41.75 - $54.5 $3,882 - $5,068	-93 Reduced 0.75%	12,281 $0
Q3 2022 Oct 26, 2022	SELL	$43.76 - $53.42 $318,397 - $388,683	-7,276 Reduced 37.03%	12,374 $541,000
Q1 2022 May 05, 2022	SELL	$45.75 - $56.69 $25,162 - $31,179	-550 Reduced 2.72%	19,650 $1.02 Million
Q4 2021 Jan 18, 2022	BUY	$41.32 - $61.25 $7,024 - $10,412	170 Added 0.85%	20,200 $1.19 Million
Q3 2021 Oct 13, 2021	BUY	$39.25 - $50.42 $282,600 - $363,024	7,200 Added 56.12%	20,030 $861,000
Q2 2021 Jul 14, 2021	BUY	$35.91 - $40.68 $67,438 - $76,397	1,878 Added 17.15%	12,830 $502,000
Q1 2021 May 13, 2021	SELL	$33.49 - $37.77 $23,108 - $26,061	-690 Reduced 5.93%	10,952 $397,000
Q4 2020 Jan 19, 2021	BUY	$33.47 - $42.56 $18,408 - $23,408	550 Added 4.96%	11,642 $429,000
Q3 2020 Oct 13, 2020	BUY	$31.75 - $37.25 $16,097 - $18,885	507 Added 4.79%	11,092 $407,000
Q3 2019 Oct 22, 2019	SELL	$32.49 - $42.13 $6,238 - $8,088	-192 Reduced 1.78%	10,585 $380,000
Q2 2019 Jul 16, 2019	SELL	$36.98 - $41.52 $7,395 - $8,304	-200 Reduced 1.82%	10,777 $467,000
Q1 2019 Apr 16, 2019	SELL	$37.5 - $41.2 $12,187 - $13,390	-325 Reduced 2.88%	10,977 $466,000
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $4,618 - $5,602	134 Added 1.2%	11,302 $498,000
Q2 2018 Jul 13, 2018	SELL	$32.98 - $35.16 $12,400 - $13,220	-376 Reduced 3.26%	11,168 $415,000
Q1 2018 Apr 16, 2018	BUY	$31.91 - $37.02 $2,648 - $3,072	83 Added 0.72%	11,544 $410,000
Q4 2017 Jan 17, 2018	BUY	$33.26 - $35.29 $11,641 - $12,351	350 Added 3.15%	11,461 $415,000
Q3 2017 Oct 19, 2017	BUY	$31.0 - $34.15 $344,441 - $379,440	11,111	11,111 $397,000

Others Institutions Holding PFE

# of Institutions

3,261

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln Capital LLC with notifications on news.

Account

Lincoln Capital LLC Pfizer Inc Transaction History